Sara Angleman, PhD, MPhil

PPD Observational Studies, Thermo Fisher Scientific, Sweden

Poster(s):

• (SLA-050) Mandated long-term follow-up studies of patients treated with gene and cell therapies approved in the European Union (EU): An analysis of commonalities and variations
  Sunday, August 24, 2025

  12:15 PM - 1:15 PM ET

• (SLA-049) Post-approval Real-world Studies of RNA therapies in the EU: What Can We Learn from Study Characteristics?
  Sunday, August 24, 2025

  12:15 PM - 1:15 PM ET

• (A-359) Vaccine-related studies listed in the Heads of Medicines Agencies-European Medicines Agency (HMA-EMA) Catalogue of Real-World Data studies: What can we learn from study characteristics?
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET